202 related articles for article (PubMed ID: 21528466)
1. Mannan-binding lectin (MBL) and MBL-associated serine protease-2 in children with cancer.
Fisch U; Zehnder A; Hirt A; Niggli F; Simon A; Ozsahin H; Schlapbach L; Ammann R
Swiss Med Wkly; 2011; 141():w13191. PubMed ID: 21528466
[TBL] [Abstract][Full Text] [Related]
2. Serum concentrations of lectin-pathway components in healthy neonates, children and adults: mannan-binding lectin (MBL), M-, L-, and H-ficolin, and MBL-associated serine protease-2 (MASP-2).
Sallenbach S; Thiel S; Aebi C; Otth M; Bigler S; Jensenius JC; Schlapbach LJ; Ammann RA
Pediatr Allergy Immunol; 2011 Jun; 22(4):424-30. PubMed ID: 21226765
[TBL] [Abstract][Full Text] [Related]
3. Severe fibrosis in hepatitis C virus-infected patients is associated with increased activity of the mannan-binding lectin (MBL)/MBL-associated serine protease 1 (MASP-1) complex.
Brown KS; Keogh MJ; Tagiuri N; Grainge MJ; Presanis JS; Ryder SD; Irving WL; Ball JK; Sim RB; Hickling TP
Clin Exp Immunol; 2007 Jan; 147(1):90-8. PubMed ID: 17177967
[TBL] [Abstract][Full Text] [Related]
4. Prognosis in pediatric hematologic malignancies is associated with serum concentration of mannose-binding lectin-associated serine protease-2 (MASP-2).
Zehnder A; Fisch U; Hirt A; Niggli FK; Simon A; Ozsahin H; Schlapbach LJ; Ammann RA
Pediatr Blood Cancer; 2009 Jul; 53(1):53-7. PubMed ID: 19343776
[TBL] [Abstract][Full Text] [Related]
5. Mannan-binding lectin (MBL)-associated serine protease-1 (MASP-1), a serine protease associated with humoral pattern-recognition molecules: normal and acute-phase levels in serum and stoichiometry of lectin pathway components.
Thiel S; Jensen L; Degn SE; Nielsen HJ; Gál P; Dobó J; Jensenius JC
Clin Exp Immunol; 2012 Jul; 169(1):38-48. PubMed ID: 22670777
[TBL] [Abstract][Full Text] [Related]
6. Assays for the mannan-binding lectin pathway.
Gadjeva M; Thiel S; Jensenius JC
Curr Protoc Immunol; 2004 Feb; Chapter 13():Unit 13.6. PubMed ID: 18432925
[TBL] [Abstract][Full Text] [Related]
7. Bipolar and panic disorders may be associated with hereditary defects in the innate immune system.
Foldager L; Köhler O; Steffensen R; Thiel S; Kristensen AS; Jensenius JC; Mors O
J Affect Disord; 2014 Aug; 164():148-54. PubMed ID: 24856568
[TBL] [Abstract][Full Text] [Related]
8. Mannan-binding lectin (MBL) and MBL-associated serine protease 2 (MASP-2) genotypes in colorectal cancer.
Ytting H; Christensen IJ; Steffensen R; Alsner J; Thiel S; Jensenius JC; Hansen U; Nielsen HJ
Scand J Immunol; 2011 Feb; 73(2):122-7. PubMed ID: 21198752
[TBL] [Abstract][Full Text] [Related]
9. The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
Olesen HV; Jensenius JC; Steffensen R; Thiel S; Schiøtz PO
Clin Immunol; 2006 Dec; 121(3):324-31. PubMed ID: 17045845
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration of complement components of the lectin pathway in maintenance hemodialysis patients, and relatively higher levels of L-Ficolin and MASP-2 in Mannose-binding lectin deficiency.
Ishii M; Ohsawa I; Inoshita H; Kusaba G; Onda K; Wakabayashi M; Ohi H; Horikoshi S; Matsushita M; Tomino Y
Ther Apher Dial; 2011 Oct; 15(5):441-7. PubMed ID: 21974696
[TBL] [Abstract][Full Text] [Related]
11. Serum MASP-1 in complex with MBL activates endothelial cells.
Megyeri M; Jani PK; Kajdácsi E; Dobó J; Schwaner E; Major B; Rigó J; Závodszky P; Thiel S; Cervenak L; Gál P
Mol Immunol; 2014 May; 59(1):39-45. PubMed ID: 24472859
[TBL] [Abstract][Full Text] [Related]
12. Increased complement classical and mannan-binding lectin pathway activities in schizophrenia.
Mayilyan KR; Arnold JN; Presanis JS; Soghoyan AF; Sim RB
Neurosci Lett; 2006 Sep; 404(3):336-41. PubMed ID: 16860475
[TBL] [Abstract][Full Text] [Related]
13. [Plasma mannan?binding lectin and MBL?associated serine protease 2 in patients with hepatocellular carcinoma].
Li J; Zhu LY; Zuo DM; Zhang LY; Lu X; Chen ZL; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Dec; 37(12):1667-1672. PubMed ID: 29292263
[TBL] [Abstract][Full Text] [Related]
14. [Correlation among serum MBL, MASP-2, HsCRP and C
Chen S; Ma BL; Cao MQ; Yu HJ; Ma XM
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Oct; 36(10):1340-1344. PubMed ID: 27777195
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of mannan-binding lectin (MBL)-associated serine proteases (MASPs) and MBL-associated protein in cardio- and cerebrovascular diseases.
Frauenknecht V; Thiel S; Storm L; Meier N; Arnold M; Schmid JP; Saner H; Schroeder V
Clin Exp Immunol; 2013 Jul; 173(1):112-20. PubMed ID: 23607747
[TBL] [Abstract][Full Text] [Related]
16. Circulating levels of mannan-binding lectin (MBL) and MBL-associated serine protease 2 in endemic pemphigus foliaceus.
Messias-Reason I; Bosco DG; Nisihara RM; Jakobsen LH; Petzl-Erler ML; Jensenius JC
Clin Exp Dermatol; 2008 Jul; 33(4):495-7. PubMed ID: 18498410
[TBL] [Abstract][Full Text] [Related]
17. Genetic influences on mannan-binding lectin (MBL) and mannan-binding lectin associated serine protease-2 (MASP-2) activity.
Sorensen GL; Petersen I; Thiel S; Fenger M; Christensen K; Kyvik KO; Sørensen TI; Holmskov U; Jensenius JC
Genet Epidemiol; 2007 Jan; 31(1):31-41. PubMed ID: 17096357
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of MBL-MASP complexes.
Mayilyan KR; Presanis JS; Arnold JN; Hajela K; Sim RB
Mol Immunol; 2006 Mar; 43(8):1286-92. PubMed ID: 16102832
[TBL] [Abstract][Full Text] [Related]
19. Co-complexes of MASP-1 and MASP-2 associated with the soluble pattern-recognition molecules drive lectin pathway activation in a manner inhibitable by MAp44.
Degn SE; Jensen L; Olszowski T; Jensenius JC; Thiel S
J Immunol; 2013 Aug; 191(3):1334-45. PubMed ID: 23785123
[TBL] [Abstract][Full Text] [Related]
20. Activation of the lectin pathway of complement by cardiopulmonary bypass contributes to the development of systemic inflammatory response syndrome after paediatric cardiac surgery.
Pągowska-Klimek I; Świerzko AS; Michalski M; Głowacka E; Szala-Poździej A; Sokołowska A; Moll M; Krajewski WR; Romak J; Cedzyński M
Clin Exp Immunol; 2016 May; 184(2):257-63. PubMed ID: 26703090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
